Wang Jinxing, Yuan Lushun, Liu Xingnian, Wang Gang, Zhu Yuan, Qian Kaiyu, Xiao Yu, Wang Xinghuan
Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Laboratory of Precision Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Oncol Lett. 2018 Jun;15(6):9133-9141. doi: 10.3892/ol.2018.8473. Epub 2018 Apr 12.
Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. The present study was conducted to explore the mechanisms and identify the potential target genes for ccRCC using bioinformatics analysis. The microarray data of GSE15641 were screened on Gene-Cloud of Biotechnology Information (GCBI). A total of 32 ccRCC samples and 23 normal kidney samples were used to identify differentially expressed genes (DEGs) between them. Subsequently, the clustering analysis and functional enrichment analysis of these DEGs were performed, followed by protein-protein interaction (PPI) network, and pathway relation network. Additionally, the most significant module based on PPI network was selected, and the genes in the module were identified as hub genes. Furthermore, transcriptional level, translational level and survival analyses of hub genes were performed to verify the results. A total of 805 genes, 403 upregulated and 402 downregulated, were differentially expressed in ccRCC samples compared with normal controls. The subsequent bioinformatics analysis indicated that the small molecule metabolic process and the metabolic pathway were significantly enriched. A total of 7 genes, including membrane metallo-endopeptidase (), albumin (), cadherin 1 (), prominin 1 (), chemokine () ligand 12 (), protein tyrosine phosphatase receptor type C () and intercellular adhesion molecule 1 () were identified as hub genes. In brief, the present study indicated that these candidate genes and pathways may aid in deciphering the molecular mechanisms underlying the development of ccRCC, and may be used as therapeutic targets and diagnostic biomarkers of ccRCC.
透明细胞肾细胞癌(ccRCC)是最常见的肾癌类型。本研究旨在通过生物信息学分析探索ccRCC的发病机制并确定潜在的靶基因。在生物技术信息基因云(GCBI)上筛选了GSE15641的微阵列数据。共使用32例ccRCC样本和23例正常肾样本确定它们之间的差异表达基因(DEG)。随后,对这些DEG进行聚类分析和功能富集分析,接着构建蛋白质-蛋白质相互作用(PPI)网络和通路关系网络。此外,基于PPI网络选择最显著的模块,并将该模块中的基因确定为枢纽基因。进一步对枢纽基因进行转录水平、翻译水平和生存分析以验证结果。与正常对照相比,ccRCC样本中共有805个基因差异表达,其中403个上调,402个下调。随后的生物信息学分析表明小分子代谢过程和代谢途径显著富集。共有7个基因被确定为枢纽基因,包括膜金属内肽酶()、白蛋白()、钙黏蛋白1()、多配体蛋白聚糖1()、趋化因子()配体12()、蛋白酪氨酸磷酸酶受体C型()和细胞间黏附分子1()。简而言之,本研究表明这些候选基因和途径可能有助于阐明ccRCC发生发展的分子机制,并可作为ccRCC的治疗靶点和诊断生物标志物。